K-tab and Death - a phase IV clinical study of FDA data

Summary:

Death is reported as a side effect among people who take K-tab (potassium chloride), especially for people who are female, 60+ old, also take Lasix, and have Multiple myeloma.

The study is created by eHealthMe based on reports of 927 people who have side effects when taking K-tab from the FDA, and is updated regularly.

What is K-tab?

K-tab has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 974 K-tab users. Check the latest studies of K-tab.

On Jul, 10, 2026

927 people reported to have side effects when taking K-tab.
Among them, 49 people (5.29%) died.

Among these 49 people:

What is the gender of people who died when taking K-tab? *

female: 56.25 %
male: 43.75 %

What is the age of people who died when taking K-tab? *

What are other drugs people take besides K-tab? *

What are other side effects people have before they died? *

Weakness: 11 people, 22.45%
Back Pain: 9 people, 18.37%
Dyspnea (difficult or laboured breathing): 8 people, 16.33%
Fatigue (feeling of tiredness): 8 people, 16.33%
Oedema Peripheral (superficial swelling): 8 people, 16.33%
Skin Ulcer: 7 people, 14.29%
Pneumonia: 7 people, 14.29%
Pulmonary Embolism (blockage of the main artery of the lung): 7 people, 14.29%
Anaemia (lack of blood): 7 people, 14.29%
Thrombocytopenia (decrease of platelets in blood): 7 people, 14.29%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 9 people, 18.37%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 8 people, 16.33%
Pain: 7 people, 14.29%
Chronic Graft Versus Host Disease (immune cells attack the host's body cells after transplant): 5 people, 10.20%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 5 people, 10.20%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 4 people, 8.16%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 4 people, 8.16%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 2 people, 4.08%
Neuropathy Peripheral (surface nerve damage): 2 people, 4.08%
Dyspnea (difficult or laboured breathing): 2 people, 4.08%

* Approximation only. Some reports may have incomplete information.

Related studies:

Effectiveness of, long term effects of, and alternative drugs to K-tab:

K-tab (974 reports)

Expand to all the drugs that have ingredients of potassium chloride:

Death and drugs with ingredients of potassium chloride (3,547 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of K-tab:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Death:

Death (3,127 drugs)

Browse all the conditions that are associated with Death:

Death (3,686 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on potassium chloride (the active ingredients of K-tab) and K-tab (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.